Methacrylic Acid - Methyl Methacrylate Copolymer (1:2)
Medically reviewed by Drugs.com. Last updated on Sep 12, 2024.
Excipient (pharmacologically inactive substance)
What is it?
Methacrylic acid - methyl methacrylate copolymer (1:2), also known as methacrylic acid copolymer, Type B - NF, is an excipient used in pharmaceutical manufacturing.
It is a solid white powder with dissolution above pH of 7.0, and is used in enteric coatings for fast dissolution in the upper bowel, for granulation of drug substances in powder form for controlled-release, and for site-specific drug delivery. It is typically released in the upper bowel of the gastrointestinal tract.[1]
Some examples of medications containing Methacrylic Acid - Methyl Methacrylate Copolymer (1:2)
- Cartia XT 180 mg
- Cartia XT 240 mg
- Cartia XT 120 mg
- Dexilant 30 mg
- Dexilant 60 mg
- Diltiazem Hydrochloride Extended-Release (CD) 300 mg
- Diltiazem Hydrochloride Extended-Release (SR) 120 mg
- Lamotrigine Extended-Release 100 mg
- Lamotrigine Extended-Release 200 mg
- Lamotrigine Extended-Release 25 mg
- Lialda 1.2 g
- Mesalamine Delayed-Release 1.2 g
- Mesalamine Delayed-Release 1.2 g
- Metoprolol Succinate Extended-Release 100 mg
- Metoprolol Succinate Extended-Release 50 mg
- Metoprolol Succinate Extended-Release 25 mg
- Nifedical XL 30 mg
- Nifedical XL 60 mg
- Omeprazole Magnesium Delayed-Release 20 mg (base)
- Rytary carbidopa 61.25 mg / levodopa 245 mg
References
- Evonik Industries. Eudragit. Eudragit S 100. Description. Accessed 8/15/2012. http://eudragit.evonik.com/product/eudragit/en/products-services/eudragit-products/enteric-formulations/s-100/pages/default.aspx
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.